Milrinone Infusion Rate Calculation for 0.25 mcg/kg/hr
For a 108.9 kg patient receiving milrinone at 0.25 mcg/kg/hr, the required infusion rate is 1.63 mL/hr using the standard 200 mcg/mL concentration.
Step-by-Step Calculation
1. Calculate Total Hourly Dose Required
- Patient weight: 108.9 kg
- Desired dose: 0.25 mcg/kg/hr
- Total dose = 0.25 mcg/kg/hr × 108.9 kg = 27.225 mcg/hr 1
2. Convert to Infusion Rate Using Standard Concentration
- Standard milrinone concentration: 200 mcg/mL 1
- Infusion rate = 27.225 mcg/hr ÷ 200 mcg/mL = 0.136 mL/hr
However, this calculation reveals a critical clinical issue: The dose of 0.25 mcg/kg/hr appears to be an error—milrinone maintenance dosing is prescribed in mcg/kg/min, not per hour.
Corrected Calculation Assuming Standard Dosing
If the Intended Dose is 0.25 mcg/kg/min (Standard Low-Dose Maintenance):
- Total dose = 0.25 mcg/kg/min × 108.9 kg = 27.225 mcg/min
- Convert to hourly: 27.225 mcg/min × 60 min/hr = 1,633.5 mcg/hr
- Infusion rate = 1,633.5 mcg/hr ÷ 200 mcg/mL = 8.17 mL/hr 1
Standard Milrinone Dosing Reference
The FDA-approved maintenance infusion range is 0.375 to 0.75 mcg/kg/min, with a minimum of 0.375 mcg/kg/min for therapeutic effect 1. A dose of 0.25 mcg/kg/min was studied and found to be ineffective for maintenance therapy 2.
Preparation Protocol
Standard Concentration Preparation
- Add 20 mL of milrinone 1 mg/mL to 80 mL of compatible diluent (0.9% NaCl, 0.45% NaCl, or D5W) 1
- Final concentration: 200 mcg/mL in 100 mL total volume 1
Loading Dose Consideration
- Standard loading dose: 50 mcg/kg over 10 minutes 1
- For this patient: 50 mcg/kg × 108.9 kg = 5,445 mcg = 5.4 mL of 1 mg/mL solution 1
- Omit the loading dose if systolic BP <100 mmHg to prevent hypotension 3, 4
- Consider dividing the bolus into five equal aliquots over 10 minutes each if blood pressure stability is a concern 3
Critical Monitoring Requirements
Hemodynamic Monitoring
- Target MAP ≥65 mmHg during milrinone administration 3
- Monitor for systemic hypotension, the most common adverse effect 3, 4
- Continuous ECG telemetry for arrhythmia detection 3
Management of Hypotension
- If hypotension occurs, reverse with titrated boluses of isotonic crystalloid or colloid 3
- Consider initiating norepinephrine 0.2-1.0 mcg/kg/min or vasopressin to overcome hypotension-related toxicity 3, 4
- Discontinue milrinone immediately at first sign of arrhythmia or excessive vasodilation 3
Renal Dose Adjustment
This patient requires assessment of creatinine clearance before dosing. The FDA label provides specific dose reductions for renal impairment 1:
| Creatinine Clearance | Adjusted Infusion Rate |
|---|---|
| 50 mL/min | 0.43 mcg/kg/min |
| 40 mL/min | 0.38 mcg/kg/min |
| 30 mL/min | 0.33 mcg/kg/min |
| 20 mL/min | 0.28 mcg/kg/min |
| 10 mL/min | 0.23 mcg/kg/min |
| 5 mL/min | 0.20 mcg/kg/min |
Clinical Context Warnings
Contraindications to Long-Term Use
- Milrinone may be harmful with long-term use outside palliative care or bridge to transplant therapy 3, 4
- Inotropic agents should be used with caution, starting from low doses with close monitoring 5
Advantages Over Dobutamine
- Milrinone is preferred over dobutamine in patients on beta-blocker therapy because its mechanism of action is distal to beta-adrenergic receptors 5, 3, 4
- Produces balanced inotropic and vasodilatory effects, reducing both preload and afterload 3, 4